Back to mobile site

Jefferies Maintains a 'Buy' on Insulet Corp (PODD)Waiting for the Next Gen Pod

February 10, 2012 1:29 PM EST
Get Alerts PODD Hot Sheet
Price: $148.16 +0.88%

Rating Summary:
    22 Buy, 17 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Jefferies maintains a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target raised from $21 to $24.

Jefferies analyst says, "Insulet closed out 2011 with 4Q sales of $47.2mn, largely in-line with expectations. The company remains in active communication with the FDA on the next gen pod, with approval expected by the end of 1Q/early 2Q. The launch of the next gen pod is anticipated at ADA in June and will have a positive impact on both revenue growth and profitability."

Jefferies lowers FY12 EPS loss from (0.42) to (0.90) and FY13 from $0.34 to (0.05).

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $19.88 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co